Giunta, Emilio Francesco
Schepisi, Giuseppe
Bleve, Sara
Serra, Riccardo
Brighi, Nicole
Torresan, Irene
Tassinari, Elisa
Zanuccoli, Sofia
Lolli, Cristian
Article History
Received: 11 August 2025
Accepted: 19 January 2026
First Online: 14 February 2026
Declarations
:
: Not applicable.
: Not applicable.
: Nicole Brighi received Advisory board or Speaker honoraria from Bristol-Myers Squibb, Gentili Oncology, Johnson and Johnson; Travel support from Ipsen, Novartis, Janssen-Cilag, Pfizer, Advanced Accelerator Applications, Bayer.The other authors have no competing interests to declare that are relevant to the content of this article.